Regulus Therapeutics Inc (RGLS)

[Tekterra]

I am new doing DD on this. So it seems they are focusing on RG-012 phase II trial to valuable efficiency. They changed the trial design to 40 people double blind, result expected year end.

Made an offering at 0.91 and seems like company officers have bough in on that offering with good number of shares.

So RG-012 result seems like a make or break since they have discontinued other candidates.

What kind of market size are we looking at here since there have been no real treatment out there?